<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="222673">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00184275</url>
  </required_header>
  <id_info>
    <org_study_id>12621</org_study_id>
    <nct_id>NCT00184275</nct_id>
  </id_info>
  <brief_title>Characterization of Brain Metastases</brief_title>
  <official_title>Brain Metastases Tissue Characterized by High-resolution Magic Angle Spinning MR and Micro Array</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Royal Norwegian Ministry of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to characterize tumour biological markers in brain metastases tissue from
      patients with different primary tumour by using ex vivo techniques as high-resolution magic
      angle spinning MR spectroscopy and micro array.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2005</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">26</enrollment>
  <condition>Neoplasm Metastasis</condition>
  <condition>Lung Neoplasms</condition>
  <condition>Breast Neoplasms</condition>
  <condition>Melanoma</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      frozen tumor tissue samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with brain metastases
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of brain metastases

        Exclusion Criteria:

          -  children

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steinar Lundgren, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Cancer Clinic, St.Olavs Hospital Trondheim University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ingrid S Gribbestad, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Norwegian University of Science and Technology, Faculty of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Norwegian University of Science and Technology, Faculty of Medicine</name>
      <address>
        <city>Trondheim</city>
        <zip>N-7489</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Sjøbakk TE, Johansen R, Bathen TF, Sonnewald U, Kvistad KA, Lundgren S, Gribbestad IS. Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T. BMC Cancer. 2007 Jul 27;7:141.</citation>
    <PMID>17662122</PMID>
  </reference>
  <results_reference>
    <citation>Sjøbakk TE, Vettukattil R, Gulati M, Gulati S, Lundgren S, Gribbestad IS, Torp SH, Bathen TF. Metabolic profiles of brain metastases. Int J Mol Sci. 2013 Jan 22;14(1):2104-18. doi: 10.3390/ijms14012104.</citation>
    <PMID>23340650</PMID>
  </results_reference>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 6, 2014</lastchanged_date>
  <firstreceived_date>September 13, 2005</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Brain metastasis</keyword>
  <keyword>HR MAS spectroscopy</keyword>
  <keyword>Tissue micro array</keyword>
  <keyword>DNA micro array</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
